1. Latest Perspectives in PAD: How to Improve Outcomes

2. PAD: A Global Burden

3. PAD: A Generalized Process

4. PAD: Definitions

5. Risk Factors for PAD

6. Diagnosis: Ankle Brachial Index

7. CONTENT NO LONGER AVAILABLE
Reproduced with permission. AHA website.

8. PAD: Treatment

9. AHA/ACC Guidelines: Antiplatelet Agents

10. EUCLID: Primary Efficacy Endpoint

11. Latest Perspectives in PAD: How to Improve Outcomes?

12. COMPASS: CAD and PAD Groups

13. COMPASS: PAD Subgroup

14. COMPASS: PAD Subgroup (cont)

15. COMPASS: Incidence of Death Before and After MALE
CONTENT NO LONGER AVAILABLE
doi: /j.jacc [Epub ahead of print]
Rate are /100 pt-years
Reprinted from J Am Coll Cardiol, pii: S (18) , Anand SS, Caron F, Eikelboom JW, et al, Major adverse limb events in lower extremity peripheral artery disease: COMPASS trial, Copyright 2018, with permission from Elsevier.

16. COMPASS: Incidence of Amputation Before and After MALE
CONTENT NO LONGER AVAILABLE
doi: /j.jacc [Epub ahead of print]
Reprinted from J Am Coll Cardiol, pii: S (18) , Anand SS, Caron F, Eikelboom JW, et al, Major adverse limb events in lower extremity peripheral artery disease: COMPASS trial, Copyright 2018, with permission from Elsevier.

17. COMPASS: Prognosis After MALE by Treatment Group

18. COMPASS: Patients With MALE Index Event
CONTENT NO LONGER AVAILABLE
doi: /j.jacc
Cox proportional hazards models with the MALE index event modelled as a time-dependent covariate
*considering only those outcomes that did not occur on the same day as the index MALE
Reprinted from J Am Coll Cardiol, pii: S (18) , Anand SS, Caron F, Eikelboom JW, et al, Major adverse limb events in lower extremity peripheral artery disease: COMPASS trial, Copyright 2018, with permission from Elsevier.

19. VOYAGER PAD: Study Design

20. Latest Perspectives in PAD: How to Improve Outcomes

21. Overview

22. PAD: A Polyvascular Disease

23. PAD: Increased Risk for MACE

24. AHA/ACC Guidelines: Antiplatelet Agents

25. PLATO and PEGASUS: PAD Subanalysis

26. EUCLID: Primary Efficacy Endpoint

27. Anticoagulation in PAD: WAVE

28. Latest Perspectives in PAD: How to Improve Outcomes

29. Lower Extremity Artery Disease: "LEAD"

30. ESC Guidelines

31. Measuring ABI

32. Therapeutic Approach to PAD

33. Limitations of Treatment

34. ESC Guidelines: Antiplatelet Therapy

35. COMPASS

36. Summary

37. Summary (cont)

38. Abbreviations

39. Abbreviations (cont)